Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 6/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31359685 | 0.85 | DGAT1 (0.34) | DGAT1 | |
| SCHEMBL25758167 | 0.78 | HTR2A (0.35) | HSP90AA1TRAP1HTR2AHTR2C | |
| SCHEMBL24344356 | 0.78 | DGAT1 (0.36) | DGAT1HTR2AHTR2C | |
| SCHEMBL25049226 | 0.77 | DGAT1 (0.34) | DGAT1HTR2AHTR2C | |
| SCHEMBL30498388 | 0.76 | HTR2A (0.34) | HSP90AA1TRAP1HTR2AHTR2C | |
| SCHEMBL27199332 | 0.76 | HTR2A (0.34) | HSP90AA1TRAP1HTR2AHTR2C | |
| SCHEMBL25758951 | 0.75 | LRRK2 (0.34) | HSP90AA1TRAP1HTR2AHTR2C | |
| SCHEMBL31138676 | 0.74 | TUBB4A (0.32) | DGAT1 | |
| SCHEMBL20262422 | 0.74 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL23292060 | 0.73 | DGAT1 (0.34) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727935-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | Lynk Pharmaceuticals Co. Ltd. (CN) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024255886-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024254832-A1 | TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-12-19 | — | — | WO | disclosed |